Browsing by Contributors Darius, Harald

فهرست الفبایی 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 10 of 10
PreviewIssue DateTitleContributor(s)
2019 NEJM Volume 380 Issue 16 April (15).pdf.jpg2019Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial FibrillationGoodman, Shaun G; Windecker, Stephan; Darius, Harald; Li, Jia; Averkov, Oleg; Bahit, M Cecilia; Vinereanu, Dragos; Granger, Christopher B; Alexander, John H; Investigators, Augustus
2019 Circulation Volume 140 Issue 23 December (10).pdf.jpg2019Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS TrialWindecker, Stephan; Lopes, Renato D.; Massaro, Tyler; Jones-Burton, Charlotte; Granger, Christopher B.; Aronson, Ronald; Heizer, Gretchen; Goodman, Shaun G.; Darius, Harald; Jones, W. Schuyler; Aschermann, Michael; Brieger, David; Cura, Fernando; Engstrøm, Thomas; Frid
2018 Circulation Volume 138 Issue 17 October (21).pdf.jpg2018Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesCannon, Christopher P.; Blazing, Michael a.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer a.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; De Ferrari, Gaetano M.; Ruzyllo, Witold; De Lucca, Paul; Im, KyungAh; Bohula, Erin
2019 JAMA Volume 322 Issue 18 November (23).pdf.jpg2019Ezetimibe added to statin therapy after acute coronary syndromesCannon, Christopher P.; Blazing, Michael a.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer a.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; De Ferrari, Gaetano M.; Ruzyllo, Witold; De Lucca, Paul; Im, Kyung Ah; Bohula, Eri
2015 NEJM Volume 372 Issue 25 June  (12).pdf.jpg2015Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.Cannon, Christopher P.; Blazing, Michael a.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer a.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; De Ferrari, Gaetano M.; Ruzyllo, Witold; De Lucca, Paul; Im, KyungAh; Bohula, Erin
2019 Circulation Volume 140 Issue 23 December (16).pdf.jpg2019Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS TrialVora, Amit N.; Alexander, John H.; Wojdyla, Daniel; Aronson, Ronald; Granger, Christopher B.; Darius, Harald; Windecker, Stephan; Mehran, Roxana; Averkov, Oleg; Budaj, Andrzej J; Kong, David F.; Kobalava, Zhanna; Mehta, Rajendra H.; Mirza, Zulfiqar; Guimaraes, Patricia
2011medicine article h (29).pdf.jpg2011Incidence , Prognostic Impact , and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary InterventionVerheugt, Freek W A; Steinhubl, Steven R; Hamon, Martial; Darius, Harald; Steg, Gabriel; Valgimigli, Marco; Marso, Steven P; Rao, Sunil V; Gershlick, Anthony H; Lincoff, A Michael; Mehran, Roxana; Stone, Gregg W
2019 JACC Volume 12 Issue 18 September (5).pdf.jpg2019Procedural Success Rates and Mortality in Elderly Patients With Percutaneous Coronary Intervention for Cardiogenic ShockZeymer, Uwe; Hochadel, Mathias; Karcher, Ann-Kathrin; Thiele, Holger; Darius, Harald; Behrens, Steffen; Schumacher, Burghard; Ince, Hüseyn; Hoffmeister, Hans-Martin; Werner, Nicolas; Zahn, Ralf
2015 JACC Volume 8 Issue 12 October (14).pdf.jpg2015Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet TherapyKereiakes, Dean J.; Yeh, Robert W.; Massaro, Joseph M.; Driscoll-Shempp, Priscilla; Cutlip, Donald E.; Steg, P. Gabriel; Gershlick, Anthony H.; Darius, Harald; Meredith, Ian T.; Ormiston, John; Tanguay, Jean François; Windecker, Stephan; Garratt, Kirk N.; Kandzari, Da
2018 Lancet Volume 392 Issue 10152 September (3).pdf.jpg2018Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease ( ARRIVE ): a randomised , double-blind , placebo-controlled trialGaziano, J Michael; Brotons, Carlos; Coppolecchia, Rosa; Cricelli, Claudio; Darius, Harald; Gorelick, Philip B; Howard, George; Pearson, Thomas A